HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lung cancer: progression of heat shock protein 70 in association with flap endonuclease 1 protein.

Abstract
Lung cancer is one of the leading causes of cancer deaths worldwide and existing approaches are not enough to manage, and hence, it is important to concentrate on new drug strategies. This study was aimed to identify the interacting partner of Flap endonuclease 1 (FEN1) and its role in cancer treatment. We identified a new FEN1 interacting partner confirmed it as Heat Shock Protein 70 (HSP 70), and its effect on FEN1 expression, in vitro. Additionally, we found that the 5-Fluorouracil's (5-FU) function was significantly improved when used in combination with HSP 70 inhibitor (KNK 437). The findings are interesting, elucidating the synergistic mechanism between two compounds which helps to develop a novel management strategy for over-expressed FEN1 in the lung.
SUPPLEMENTARY INFORMATION:
The online version contains supplementary material available at 10.1007/s13205-020-02598-3.
AuthorsChandra Sekhar Kathera, Jiang Longwei, Avilala Janardhan, Lihong Qin, Qi Zhang, Wu Lan, Jia Shaochang, Zhigang Guo
Journal3 Biotech (3 Biotech) Vol. 11 Issue 3 Pg. 141 (Mar 2021) ISSN: 2190-572X [Print] Germany
PMID33708464 (Publication Type: Journal Article)
Copyright© King Abdulaziz City for Science and Technology 2021.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: